AU Patent

AU2011295909B2 — Crystalline forms of a factor Xa inhibitor

Assigned to Portola Pharmaceuticals LLC · Expires 2015-05-21 · 11y expired

What this patent protects

Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.

USPTO Abstract

Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011295909B2
Jurisdiction
AU
Classification
—
Expires
2015-05-21
Drug substance claim
No
Drug product claim
No
Assignee
Portola Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.